Ray Dalio’s CL Holdings & Trades

First Buy
Q3 2014
Duration Held
45 Quarters
Largest Add
Q1 2022
+728,497 Shares
Current Position
120,680 Shares
$9.65 M Value

Ray Dalio's CL Position Overview

Ray Dalio (via Bridgewater Associates, Lp) currently holds 120,680 shares of Colgate-Palmolive Company (CL) worth $9.65 M, representing 0.04% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 45 quarters.

Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in CL, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2022, adding 728,497 shares. Largest reduction occurred in Q3 2024, reducing 672,617 shares.

Analysis based on 13F filings available since 2013 Q2

Ray Dalio's Colgate-Palmolive Company (CL) Holding Value Over Time

Track share changes against reported price movement

Quarterly Colgate-Palmolive Company (CL) Trades by Ray Dalio

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2014 +21,806 New Buy 21,806 $65.21
Q4 2014 +31,665 Add 145.21% 53,471 $69.20
Q1 2015 -53,471 Sold Out 53,471 $0.00
Q4 2015 +122,706 New Buy 122,706 $66.62
Q1 2016 -122,706 Sold Out 122,706 $0.00
Q2 2016 +11,300 New Buy 11,300 $73.19
Q3 2016 -11,300 Sold Out 11,300 $0.00
Q4 2016 +7,768 New Buy 7,768 $65.40
Q1 2017 -7,768 Sold Out 7,768 $0.00
Q3 2018 +90,945 New Buy 90,945 $66.95
Q4 2018 +488,966 Add 537.65% 579,911 $59.52
Q1 2019 -576,766 Reduce 99.46% 3,145 $68.68
Q2 2019 -3,145 Sold Out 3,145 $0.00
Q3 2019 +20,802 New Buy 20,802 $73.50
Q4 2019 -20,802 Sold Out 20,802 $0.00
Q1 2020 +31,361 New Buy 31,361 $66.36
Q2 2020 -31,361 Sold Out 31,361 $0.00
Q3 2020 +426,955 New Buy 426,955 $77.15
Q4 2020 +474,542 Add 111.15% 901,497 $85.51
Q1 2021 +212,672 Add 23.59% 1.11 M $78.83
Q2 2021 +559,857 Add 50.25% 1.67 M $81.35
Q3 2021 -6,986 Reduce 0.42% 1.67 M $75.58
Q4 2021 +231,899 Add 13.91% 1.9 M $85.34
Q1 2022 +728,497 Add 38.36% 2.63 M $75.83
Q2 2022 -337,239 Reduce 12.84% 2.29 M $80.14
Q3 2022 +139,805 Add 6.10% 2.43 M $70.25
Q4 2022 -537,268 Reduce 22.11% 1.89 M $78.79
Q1 2023 -188,986 Reduce 9.98% 1.7 M $75.15
Q2 2023 -64,120 Reduce 3.76% 1.64 M $77.04
Q3 2023 +60,019 Add 3.66% 1.7 M $71.11
Q4 2023 -152,761 Reduce 8.99% 1.55 M $79.71
Q1 2024 -254,087 Reduce 16.43% 1.29 M $90.05
Q2 2024 -13,561 Reduce 1.05% 1.28 M $97.04
Q3 2024 -672,617 Reduce 52.58% 606,621 $103.81
Q4 2024 -456,387 Reduce 75.23% 150,234 $90.91
Q1 2025 -89,572 Reduce 59.62% 60,662 $93.70
Q2 2025 -14,712 Reduce 24.25% 45,950 $90.90
Q3 2025 +74,730 Add 162.63% 120,680 $79.94

Ray Dalio's Colgate-Palmolive Company Investment FAQs

Ray Dalio first purchased Colgate-Palmolive Company (CL) in Q3 2014, acquiring 21,806 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ray Dalio has held Colgate-Palmolive Company (CL) for 45 quarters since Q3 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ray Dalio's largest addition to Colgate-Palmolive Company (CL) was in Q1 2022, adding 2,627,436 shares worth $199.24 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 120,680 shares of Colgate-Palmolive Company (CL), valued at approximately $9.65 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Colgate-Palmolive Company (CL) represents approximately 0.04% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ray Dalio's peak holding in Colgate-Palmolive Company (CL) was 2,627,436 shares, as reported at the end of Q1 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.